InMed to Attend the 27th Annual Global Investment Conference Hosted by H.C. Wainwright
InMed Pharmaceuticals to Present at H.C. Wainwright Conference
InMed Pharmaceuticals Inc., a company focused on developing proprietary small molecule drug candidates targeting the CB1/CB2 receptors, will be participating in the H.C. Wainwright 27th Annual Global Investment Conference in New York from September 8-10, 2025.
The conference, which will also feature Stran & Company (SWAG), WhiteFiber, Inc., Ideal Power (IPWR), and ZenaTech Inc., will see InMed's management team conducting one-on-one meetings with investors.
During the conference, Mr. Michael Woudenberg, InMed's Chief Operating Officer, will highlight updates and progress of InMed's pipeline. The presentation will include recent data from InMed's leading pharmaceutical program INM-901 in the treatment of Alzheimer's. This data was recently presented at the Alzheimer's Association International Conference (AAIC) 2025.
InMed's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular, and dermatological indications. The corporate presentation will also serve as a platform to discuss recent updates and progress with InMed's pipeline, including recent data from their lead program INM-901 in the treatment of Alzheimer's.
The webcast of the presentation will be available for 90 days at this link: https://journey.ct.events/view/09f2e465-e7f2-45b7-83d6-e1fb4303ebc4. For those unable to attend the conference, the webcast will also be available on the InMed Investor Relations Events page: https://www.inmedpharma.com/investors/events/.
Investors who wish to schedule a meeting with InMed's management team can contact Colin Clancy, Vice President of Investor Relations and Corporate Communications, at T: +1.604.416.0999 or E: [email protected].
The risks and uncertainties associated with InMed's stand-alone business are disclosed in their Annual Report on Form 10-K and other filings with the Securities and Exchange Commission at www.sec.gov.
This news release contains forward-looking information regarding the corporate presentation.
The source of this press release is Newsfile via QuoteMedia.
Read also:
- Recognition of Exceptional Patient Care: Top Staff Honored by Medical Center Board
- A continuous command instructing an entity to halts all actions, repeated numerous times.
- Oxidative Stress in Sperm Abnormalities: Impact of Reactive Oxygen Species (ROS) on Sperm Harm
- Is it possible to receive the hepatitis B vaccine more than once?
